PNC Financial Services Group
HCAT icon

PNC Financial Services Group’s Health Catalyst HCAT Stock Holding History

PNC Financial Services Group’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.7K Sell
2,137
-177
-8% -$338 ﹤0.01% 4632
2026
Q2 		$4.6K Sell
2,314
-3,286
-59% -$4.74K ﹤0.01% 4419
2026
Q1 		$7.11K Buy
5,600
+4,506
+412% +$8.48K ﹤0.01% 4109
2025
Q4 		$2.62K Buy
1,094
+698
+176% +$1.91K ﹤0.01% 4465
2025
Q3 		$1.13K Buy
396
+322
+435% +$1.1K ﹤0.01% 4648
2025
Q2 		$279 Buy
74
+26
+54% +$102 ﹤0.01% 4770
2025
Q1 		$217 Sell
48
-2,099
-98% -$11.1K ﹤0.01% 4767
2024
Q4 		$15.2K Buy
2,147
+30
+1% +$239 ﹤0.01% 3656
2024
Q3 		$17.2K Hold
2,117
– – ﹤0.01% 3573
2024
Q2 		$13.5K Sell
2,117
-73
-3% -$469 ﹤0.01% 3657
2024
Q1 		$16.5K Buy
2,190
+2,117
+2,900% +$19.3K ﹤0.01% 3545
2023
Q4 		$676 Sell
73
-673
-90% -$5.5K ﹤0.01% 4361
2023
Q3 		$7.55K Buy
746
+116
+18% +$1.38K ﹤0.01% 3864
2023
Q2 		$7.88K Sell
630
-378
-38% -$4.5K ﹤0.01% 3980
2023
Q1 		$11.8K Sell
1,008
-428
-30% -$5.46K ﹤0.01% 3739
2022
Q4 		$15.3K Sell
1,436
-4,397
-75% -$42.4K ﹤0.01% 3605
2022
Q3 		$57K Buy
5,833
+1,742
+43% +$23.1K ﹤0.01% 2879
2022
Q2 		$60K Sell
4,091
-179
-4% -$3.05K ﹤0.01% 2870
2022
Q1 		$111K Buy
4,270
+463
+12% +$13.1K ﹤0.01% 2652
2021
Q4 		$151K Sell
3,807
-781
-17% -$35.6K ﹤0.01% 2425
2021
Q3 		$229K Buy
4,588
+36
+0.8% +$1.96K ﹤0.01% 2113
2021
Q2 		$253K Sell
4,552
-37
-0.8% -$1.97K ﹤0.01% 2071
2021
Q1 		$215K Buy
4,589
+144
+3% +$6.98K ﹤0.01% 2132
2020
Q4 		$194K Sell
4,445
-200
-4% -$7.38K ﹤0.01% 2082
2020
Q3 		$170K Buy
4,645
+4,460
+2,411% +$151K ﹤0.01% 2025
2020
Q2 		$6K Buy
185
+51
+38% +$1.41K ﹤0.01% 3595
2020
Q1 		$4K Buy
134
+21
+19% +$642 ﹤0.01% 3634
2019
Q4 		$4K Buy
113
+7
+7% +$232 ﹤0.01% 3685
2019
Q3 		$3K Buy
+106
New +$4.17K ﹤0.01% 3809

Other funds holding HCAT

CF
CDC Financial Chicago, Illinois $209M AUM 26.53% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $13B AUM 14.15% 1-Year Est. Return
Nepsis Inc
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $212M AUM 53.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return

PNC Financial Services Group's HCAT Position: Q3 2026 in Review

PNC Financial Services Group reduced its Health Catalyst (HCAT) stake by 7.6% in Q3 2026, selling an estimated $338 and leaving 2,137 shares worth $3.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4632.

PNC Financial Services Group first reported a position in HCAT in Q3 2019 and has held it in 29 quarters since. The position peaked at $253K in Q2 2021. 76 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.

  • PNC Financial Services Group held 2,137 shares of Health Catalyst worth $3.7K as of Q3 2026.
  • PNC Financial Services Group sold 177 Health Catalyst shares in Q3 2026, an estimated $338.
  • Health Catalyst made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4632 holding.
  • PNC Financial Services Group first reported a position in Health Catalyst in Q3 2019 and has held it in 29 quarters since.
  • PNC Financial Services Group's Health Catalyst position peaked at $253K in Q2 2021.
  • 76 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.